Are ‘Patient-Centric’ Clinical Trials More than a Buzzword?

Ryan Bailey, MA, Senior Clinical Researcher, Rho

Ryan Bailey, Senior Learning and Performance Specialist, Rho

It’s not a new idea, but meaningful adoption of so-called “patient-centric” trials has been a little slow out of the gate, industry experts say. “We’ve heard this term kicked around for a while, but it feels like people are talking about it a lot more now,” says Ryan Bailey, MA, senior clinical researcher with Rho.

While there’s some truth to labeling it a buzzword in the past, Bailey believes true patient-centric approaches are on the cusp of wide adoption. It’s an “evolution” that he says will reinforce some things of long-time importance, such as patient engagement, advocacy, recruitment, retention, and rights.

Change in the macro healthcare landscape is also accelerating adoption, Bailey suggests. It’s the “democratization of information, if you will,” he says. Patients can go online and learn a lot about their conditions; whether that information is accurate or not, many patients come to their physicians armed with their own data or other findings. Patients now view themselves as customers and take a more active role in their own care.

Bailey and his colleagues will offer insights on patient-centric trials at their ACRP 2017 Meeting & Expo session, Putting Patient-Centric Principles into Practice. With more than 20 years of experience successfully implementing patient-centered strategies, these experts will share which factors matter to patients and how to design trials – from trial design, site selection, patient interaction, and data collection to study closeout – that honor their needs and desires. View Program and Schedule

ACRP 2017 Meeting & Expo

Clinical trial subjects bring those same expectations to the research environment, Bailey says—they arrive with a lot of questions…and clinical trial practitioners must be ready to respond. Otherwise, potential participants will recoil because they feel as if they aren’t being told everything, he warns. If doctors now seem wide open during their interactions with patients and trial personnel don’t follow suit, it’s going to come across as secretive behavior to today’s and tomorrow’s patient, he adds.

Empathy is also a key. “Think in terms of the patient’s experience. What does it feel like?” Bailey says.  As a participant in a clinical trial, he brings his own expertise to the trial and often shares that with colleagues. “I had a less than optimal experience and came to work at Rho a few weeks later, and it gave me a new perspective on my job,” he recalls.

Author: Michael Causey